Cargando…
Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders
Adolescents with autism have higher rates of anxiety than the general adolescent population. They often struggle to express psychological symptoms verbally where their symptoms may manifest as withdrawal and agitation. Adolescent patients with autism have higher rates of polypharmacy and high-risk p...
Autores principales: | Bose-Brill, Seuli, Xing, Jinming, Barnette, Debra J, Hanks, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626389/ https://www.ncbi.nlm.nih.gov/pubmed/29026329 http://dx.doi.org/10.2147/PGPM.S130247 |
Ejemplares similares
-
Addressing medical needs of adolescents and adults with autism spectrum disorders in a primary care setting
por: Saqr, Youssra, et al.
Publicado: (2017) -
Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy
por: Roosan, Don, et al.
Publicado: (2020) -
Autism spectrum disorders: let’s talk about glucose?
por: Hoirisch-Clapauch, Silvia, et al.
Publicado: (2019) -
Mutations in Hevin/Sparcl1 and risk of autism spectrum disorder
por: Taketomi, Takumi, et al.
Publicado: (2022) -
A randomized controlled trial of analogue pharmacogenomic testing feedback for psychotropic medications
por: Young, John, et al.
Publicado: (2022)